Frontage Laboratories | 19-Jun-2019
| Technical / White Paper
Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...
Catalent Pharma Solutions | 07-Nov-2018
| Case Study
A sponsor running a clinical trial in Israel arranged to ship their clinical trial product from Europe to a depot in Israel. With the protocol based in...
Baxter BioPharma Solutions | 05-Nov-2018
| Technical / White Paper
Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....
In May 2018 Outsourcing-Pharma.com, in association with InnovoCommerce, conducted its second annual ‘state of the industry’ survey on its user base of...
Marken: Global Life Science Supply Chain Solutions | 26-Jun-2018
| Case Study
A desperate mother in Germany urged her team of doctors to reach out to a Marken client on behalf of her two year old girl. The child was battling leukemia...
PRA Health Sciences | 17-May-2018
| Technical / White Paper
PRA’s whitepaper The Impact of Contraceptive Requirements on Pediatric Clinical Trials considers sponsors responsibilities in navigating the complex logistical...
Syne Qua Non Clinical | 16-May-2018
| Business Advice
In an era of rapid technology growth, healthcare requires low cost solutions for real-time data collection. We have come a long way from paper to EDC and...
Baxter BioPharma Solutions | 12-Mar-2018
| Technical / White Paper
There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...
Catalent Pharma Solutions | 05-Mar-2018
| Technical / White Paper
When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...
Vetter Pharma International GmbH | 07-Nov-2017
| Technical / White Paper
In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...
Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...
Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...
In May 2017, Outsourcing-Pharma.com conducted its inaugural “state of the industry” survey of its user base of pharmaceutical industry professionals, including...
Recipharm AB | 15-May-2017
| Technical / White Paper
Selecting and developing an appropriate dosage form for inhalation products can be challenging. The physicochemical properties of the API, the required...
